1.Technological progress of computer-aided detection and diagnosis of lung nodule based on CT image analysis
International Journal of Biomedical Engineering 2009;32(5):283-286,309
Lung nodules are one of the most common pathological changes, thus early detection of lung nodule is very important for the diagnosis medical treatment of lung eancer. In recent years, as the application of multi-slice spiral CT(MSCT), high-resolution CT(HRCT) and low-dose chest CTCLDCT), computer-aided diagnosis (CAD) system will be more essential and more important. Since CAD system can improve the working efficiency of doctors and provide service to more patients, has become the research hotspot and achievement has been made in relevant area internationally recently. This review summarizes the basic methods and applieations of computer-aided detection and diagnosis of lung nodule based on CT image.
2.Clinical,pathologic and prognostic analysis in children with steroid-resistant nephritic syndrome
Chongqing Medicine 2014;(30):4025-4027
Objective To study the features of clinic ,pathology and prognosis in children with steroid-resistant nephritic syn-drome(SRNS) .Methods Children with SRNS hospitalized in Division of Nephrology and Immunology in our hospital from January 2003 to December 2012 were analyzed retrospectively in clinic ,pathology and prognosis .Results 162 patients were investigated , which accounted for 10 .8% of children with Primary nephritic syndrome(PNS) ,and the mean age of onset was 6 .9 ± 3 .8 years old . Renal biopsy was performed in 132 patients ,60 of them showed mesangial proliferative glomerulonephritis(MsPGN) ,30 showed fo-cal segmental glomerulosclerosis(FSGS) ,19 showed minimal change disease(MCD) ,8 showed membranoproliferative glomerulone-phritis(MPGN) ,5 showed membranous nephropathy(MN) ,1 showed proliferative sclerosis glomerulonephritis(PSGN) .Patients with non-minimal change disease(non-MCD)had a significant prevalence of hematuria .The distribution of pathologic type among age groups and clinical classification was significantly different ,respectively(P<0 .05) .(2)132 patients were followed up ,58 of them were in complete remission ,26 were in partial remission ,15 were not in remission ,8 were dead ,and the mean time for com-plete remission was 15 months(3-84 .Prognosis correlated with pathologic type(P<0 .01) .Conclusion (1)There is a preponder-ance of non-MCD in children with SRNS ,and MsPGN and FSGS is the major pathologic type .Hematuria is a predictor of glucocor-ticoid resistance .(2)Children with SRNS have a long time proteinuria and poor prognosis .FSGS has a poor prognosis ,when com-pared with MsPGN .
3.Report on recent advances on marginal zone lymphoma in the 54th ASH annual meeting
Journal of Leukemia & Lymphoma 2013;22(1):9-10
Marginal zone lymphomas include three subgroups of lymphoma,with differences on etiology,pathogenesis,molecular cytogenetics,prognosis,as well as involved sites.Based on the reports from the latest ASH annual meeting,the present article introduces the uptodate understanding on the three subtypes of MZL.The recent advances on etioloty,pathogenesis,diagnosis and differential diagnosis were reviewed.
4.Advances in treatment of chronic lymphocytic leukemia
Journal of Leukemia & Lymphoma 2017;26(1):5-7
Great advances have been made recently in the therapy of chronic lymphocytic leukemia due mainly to the application of novel agents. In the 58th American Society of Hematology Annual Meeting, the latest outcomes of many clinical studies have been reported. The present article will review the reports and focus on the following studies on chronic lymphocytic leukemia (CLL): the long-term therapeutic outcome of BTKi and the result of combination therapy of BTKi with other agents; the short-term result of bcl-2 inhibitor in CLL; the efficacy of maintenance therapy with lenalidomide in CLL patients; CD19-CAR T-cell therapy achieved good response. Traditional immunochemotherapy with combination of fludarabine, cyclophosphamide and rituximab is still the first-line option for fit patients through long-term follow-up. The allogeneic stem cell transplantation remains a curative strategy for CLL but with stricter indication.
5.The Clinical Value of Bloodβ-hydroxybutyric Acid and Urine Ketone in the Diagnosis of Diabetic Ketosis
Journal of Kunming Medical University 2016;37(6):101-104
Objective To investigate the clinical value of bloodβ-hydroxybutyric acid and urine ketone in the diagnosis of diabetic ketosis. Methods One hundred and fifteen patients with non-ketosis diabetics (NDK group), 85 patients with diabetic ketosis (DK group) and 105 healthy people (control group) were enrolled in Chengmai People's Hospital from May 2012 to May 2014. Blood β-hydroxybutyric acid, urine ketone and blood glucose were detected; the correlation index of blood β-hydroxybutyric acid, urine ketone and blood glucose in NDK group and DK group were analyzed. The receiver operating characteristic curve (ROC) was performed in determining the diagnostic value of bloodβ-hydroxybutyric acid for diabetic ketosis. Results The level of bloodβ-hydroxybutyric acid, positive rate of bloodβ-hydroxybutyric acid, urine ketone and level of blood glucose in DK group were higher than those in NDK group and NC group (P<0.01) . Blood β-hydroxybutyric acid was positively correlated with urine ketone and blood glucose (r=0.552,P=0.000;r=0.405,P=0.010) . When urine ketone was used as diagnostic standard, the area under curve of bloodβ-hydroxybutyric acid was 0.839, the best cutoff value ofβ-hydroxybutyric acid was 0.64 mmol/L with the sensitivity was 81.6%and specificity was 89.2%. Conclusions Examinations of bloodβ-hydroxybutyric acid and urine ketone have great significance for the diagnosis of diabetic ketosis. The co-monitoring of blood β-hydroxybutyric acid and urine ketone can reduce the rates of missed diagnosis and misdiagnosis. The best cutoff value of β-hydroxybutyric acid to diagnose diabetic ketosis was 0.64 mmol/L.
6.Effectiveness of aerobic exercise on quality of life in breast cancer survivors:a meta-analysis
Chinese Journal of Nursing 2017;52(3):300-306
Objective To evaluate the effectiveness of aerobic exercise on quality of life in breast cancer survivors.Methods Electronic databases were searched.Randomized controlled trials in which aerobic exercise was compared with controls regarding quality of life in breast cancer survivors were included.Results We analyzed 12 RCT studies.Aerobic exercise significantly improved quality of life in breast cancer survivors.Seven studies which used FACT-B scale concluded that aerobic exercise could significantly improve psychological emotion,social/family function and breast-related function.The aerobic exercise aiming at breast cancer survivors who had already finished all the therapies except endocrine therapy of breast cancer,mainly comprised of short-period intervention programs (within 24 weeks),and was advised to be executed under professionals' supervision to ensure safety.Conclusion Aerobic exercise could effectively improve quality of life in breast cancer survivors,especially in aspects of psychological emotion,social/family function and breast-related function.
7.Molecular targeted therapy for esophageal cancer
Practical Oncology Journal 2015;(1):57-60
According to the 2012 estimates,esophageal cancer(EC)was the fifth commonly diagnosed cancer and the forth leading cause of cancer -related death .The incidence and mortality rates of EC have been increasing in China .Combined -modality therapy for EC is well accepted , and molecular targeted therapy be-comes a research area.Nowadays,multiple agents have been developed and studied in phase Ⅱ/Ⅲtrials,mainly including cetuximab,erlotinib,trastuzumab,bevacizumab.In this review,we focus on the development of molecular targeted therapy for EC .
8.Standardization of Adaptive Behavior Assessment System-II (6-18 Years Old) Chinese Version
Chinese Journal of Rehabilitation Theory and Practice 2016;22(4):378-382
Objective To standardize Adaptive Behavior Assessment System (ABAS)-II Chinese version to establish norm of ABAS-II Chinese version (6-18 years old). Methods International Classification of Functioning, Disability and Health (ICF) and psychological mea-surement were taken. Results Chinese version of ABAS-II (6-18 years old) was developed. The norms of general scores, main domains scores and adaptive skill scores had been established. Conclusion Chinese version of ABAS-II (6-18 years old) can be applied for the evalu-ation of adaptive behavior for Chinese children aged 6-18 years. The standardized Chinese version of ABAS-II (6-18 years old) meets the re-quirement of reliability and validity of the US version.
9.The individualized treatment for DLBCL: inadequacies of ESMO guidelines
Journal of Leukemia & Lymphoma 2013;22(9):514-516
Diffuse large B-cell lymphoma is the most common histology of non-Hodgkin lymphoma and is composed of clinically and pathologically heterogeneous group.The ESMO clinical practice guidelines stratified the diseases according to age,age-adjusted IPI and feasibility of dose-intensified approaches.While the regimens suggested by ESMO are almost the same:six to eight cycles of chemotherapy with CHOP combined with rituximah.This article discussed the inadequacies of the guideline according to the recent clinical and pre-clinical studies and the authors' personal experiences.Four deficiencies are outlined:new prognostic factors are not included for the stratification,no therapy adjustmett was advised according to the response,overload therapy for the very-low risk patient,and insufficient therapy for the young,high-risk patients.
10.Stat3 in malignant tumors: research progress
Journal of International Oncology 2011;38(1):3-5
Stat3 is a member of the STAT (signal transducer and activator of transcription) protein family. It can be activated by many cytokines, growth factors and carcinogens. Activation of Stat3 in the cytoplasm leads to its dimerization, translocation into the nucleus, DNA binding and gene transcription. Constitutively activated Stat3 is associated with cellular transformation, invasion, metastasis, angiogenesis, chemoresistance and radioresistance, and therefore suppress apoptosis of cancer.